Expression of high-mobility group box-1 in eutopic/ectopic endometrium and correlations with inflammation-related factors in adenomyosis

References

• Chen J, Porter AE, Kho KA. Current and future surgical and interventional management options for adenomyosis. Semin Reprod Med. 2020;38(2–03):1–7. doi:10.1055/s-0040-1718921.
   PubMed Web of Science ®Google Scholar
• Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016;23(2):164–185. doi:10.1016/j.jmig.2015.09.018.
   PubMed Web of Science ®Google Scholar
• Senturk LM, Imamoglu M. Adenomyosis: what is new? Womens Health (Lond). 2015;11(5):717–724. doi:10.2217/whe.15.60.
   PubMedGoogle Scholar
• Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017;40:68–81. doi:10.1016/j.bpobgyn.2016.09.006.
   PubMed Web of Science ®Google Scholar
• Donnez J, Stratopoulou CA, Dolmans MM. Uterine adenomyosis: from disease pathogenesis to a new medical approach using GnRH antagonists. Int J Environ Res Public Health. 2021;18(19):9941.
   PubMed Web of Science ®Google Scholar
• Bourdon M, Santulli P, Jeljeli M, et al. Immunological changes associated with adenomyosis: a systematic review. Hum Reprod Update. 2021;27(1):108–129. doi:10.1093/humupd/dmaa038.
   PubMed Web of Science ®Google Scholar
• Malarkey CS, Churchill ME. The high mobility group box: the ultimate utility player of a cell. Trends Biochem Sci. 2012;37(12):553–562. doi:10.1016/j.tibs.2012.09.003.
   PubMed Web of Science ®Google Scholar
• Mandke PP, Vasquez KM. Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: implications in DNA repair and immune responses. DNA Repair (Amst). 2019;83:102701. doi:10.1016/j.dnarep.2019.102701.
   PubMed Web of Science ®Google Scholar
• Yu Y, Tang D, Kang R. Oxidative stress-mediated HMGB1 biology. Front Physiol. 2015;6:93. doi:10.3389/fphys.2015.00093.
   PubMed Web of Science ®Google Scholar
• Kwak MS, Kim HS, Lee B, et al. Immunological significance of HMGB1 Post-Translational modification and redox biology. Front Immunol. 2020;11:1189. doi:10.3389/fimmu.2020.01189.
   PubMed Web of Science ®Google Scholar
• Yang H, Antoine DJ, Andersson U, et al. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol. 2013;93(6):865–873. doi:10.1189/jlb.1212662.
   PubMed Web of Science ®Google Scholar
• Diener KR, Al-Dasooqi N, Lousberg EL, et al. The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer. Immunol Cell Biol. 2013;91(7):443–450. doi:10.1038/icb.2013.25.
   PubMed Web of Science ®Google Scholar
• Nan K, Han Y, Fang Q, et al. HMGB1 gene silencing inhibits neuroinflammation via down-regulation of NF-κB signaling in primary hippocampal neurons induced by Aβ(25-35). Int Immunopharmacol. 2019;67:294–301. doi:10.1016/j.intimp.2018.12.027.
   PubMed Web of Science ®Google Scholar
• Qu D, Ling Z, Tan X, et al. High mobility group protein B1 (HMGB1) interacts with receptor for advanced glycation end products (RAGE) to promote airway smooth muscle cell proliferation through ERK and NF-κB pathways. Int J Clin Exp Pathol. 2019;12(9):3268–3278.
   PubMed Web of Science ®Google Scholar
• Guo J, Chen L, Luo N, et al. LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis. Sci Rep. 2016;6(1):21416. doi:10.1038/srep21416.
   PubMedGoogle Scholar
• Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592–601. doi:10.1016/j.rbmo.2017.06.016.
   PubMed Web of Science ®Google Scholar
• Liang S, Shi LY, Duan JY, et al. Celecoxib reduces inflammation and angiogenesis in mice with adenomyosis. Am J Transl Res. 2021;13(4):2858–2866.
   PubMed Web of Science ®Google Scholar
• Zhai J, Vannuccini S, Petraglia F, et al. Adenomyosis: mechanisms and pathogenesis. Semin Reprod Med. 2020;38(2–03):129–143. doi:10.1055/s-0040-1716687.
   PubMed Web of Science ®Google Scholar
• Kobayashi H. Endometrial inflammation and impaired spontaneous decidualization: insights into the pathogenesis of adenomyosis. Int J Environ Res Public Health. 2023;20(4):3762. doi:10.3390/ijerph20043762.
   PubMedGoogle Scholar
• Ying P, Li H, Jiang Y, et al. Qiu’s neiyi recipe regulates the inflammatory action of adenomyosis in mice via the MAPK signaling pathway. Evid Based Complement Alternat Med. 2021;2021:9791498–9791410. doi:10.1155/2021/9791498.
   PubMed Web of Science ®Google Scholar
• Goodwin GH, Sanders C, Johns EW. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem. 1973;38(1):14–19. doi:10.1111/j.1432-1033.1973.tb03026.x.
   PubMedGoogle Scholar
• Min HJ, Kim SJ, Kim TH, et al. Level of secreted HMGB1 correlates with severity of inflammation in chronic rhinosinusitis. Laryngoscope. 2015;125(7):E225–30.
   PubMed Web of Science ®Google Scholar
• Shen X, Li WQ. High-mobility group box 1 protein and its role in severe acute pancreatitis. World J Gastroenterol. 2015;21(5):1424–1435. doi:10.3748/wjg.v21.i5.1424.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Kouzaki H, Kato T, et al. HMGB1-TLR4 signaling contributes to the secretion of interleukin 6 and interleukin 8 by nasal epithelial cells. Am J Rhinol Allergy. 2016;30(3):167–172. doi:10.2500/ajra.2016.30.4300.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Ueda T, Takeyama Y, et al. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas. 2006;33(4):359–363. doi:10.1097/01.mpa.0000236741.15477.8b.
   PubMed Web of Science ®Google Scholar
• Wang X, Gao S, Song L, et al. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis. Mol Immunol. 2021;130:113–121. doi:10.1016/j.molimm.2020.11.014.
   PubMed Web of Science ®Google Scholar
• Zhou LY, Shi LY, Xiao Y. Changes of HMGB1 expression on angiogenesis of ovarian cancer and its mechanism. J Biol Regul Homeost Agents. 2016;30(1):233–238.
   PubMed Web of Science ®Google Scholar
• Rapoport BL, Steel HC, Theron AJ, et al. High mobility group box 1 in human cancer. Cells. 2020;9(7):1664. doi:10.3390/cells9071664.
   PubMed Web of Science ®Google Scholar
• Ulukus EC, Ulukus M, Seval Y, et al. Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis. Hum Reprod. 2005;20(10):2958–2963. doi:10.1093/humrep/dei154.
   PubMed Web of Science ®Google Scholar
• Mikhaleva LM, Davydov AI, Patsap OI, et al. Malignant transformation and associated biomarkers of ovarian endometriosis: a narrative review. Adv Ther. 2020;37(6):2580–2603. doi:10.1007/s12325-020-01363-5.
   PubMed Web of Science ®Google Scholar
• Luo XZ, Zhou WJ, Tao Y, et al. TLR4 activation promotes the secretion of IL-8 which enhances the invasion and proliferation of endometrial stromal cells in an autocrine manner via the FAK signal pathway. Am J Reprod Immunol. 2015;74(6):467–479. doi:10.1111/aji.12425.
   PubMed Web of Science ®Google Scholar